Maya Kotturi

Maya Kotturi is an accomplished professional in the field of preclinical and translational research, currently serving as Vice President of Preclinical Development at Infinimmune since April 2025. Previously, Kotturi held the position of Executive Director of Translational Research at IGM Biosciences, Inc., where responsibilities included leading teams to develop preclinical strategies for therapeutic IgM antibodies across various disease areas including oncology and autoimmune diseases. Kotturi's extensive experience also includes roles such as Senior Director and Director at Compugen, contributing to the development of innovative cancer therapies, and Senior Scientist at Pfizer, focusing on therapeutic cancer vaccines. Early career experience encompassed research positions at the La Jolla Institute for Allergy and Immunology and a Quality Control Manager role at Nventa Biopharmaceuticals Corporation. Kotturi holds a Ph.D. in Microbiology and Immunology from The University of British Columbia and a B.Sc. in Biochemistry and Microbiology from the University of Victoria.